164 related articles for article (PubMed ID: 35318648)
1. Tumour-associated antigenic peptides are present in the HLA class I ligandome of cancer cell line derived extracellular vesicles.
Kumar P; Boyne C; Brown S; Qureshi A; Thorpe P; Synowsky SA; Shirran S; Powis SJ
Immunology; 2022 Jun; 166(2):249-264. PubMed ID: 35318648
[TBL] [Abstract][Full Text] [Related]
2. What Is the Role of HLA-I on Cancer Derived Extracellular Vesicles? Defining the Challenges in Characterisation and Potential Uses of This Ligandome.
Boyne C; Lennox D; Beech O; Powis SJ; Kumar P
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948350
[TBL] [Abstract][Full Text] [Related]
3. Acid Stripping after Infection Improves the Detection of Viral HLA Class I Natural Ligands Identified by Mass Spectrometry.
Lorente E; Marcilla M; de la Sota PG; Quijada-Freire A; Mir C; López D
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638844
[TBL] [Abstract][Full Text] [Related]
4. Mapping the HLA ligandome landscape of acute myeloid leukemia: a targeted approach toward peptide-based immunotherapy.
Berlin C; Kowalewski DJ; Schuster H; Mirza N; Walz S; Handel M; Schmid-Horch B; Salih HR; Kanz L; Rammensee HG; Stevanović S; Stickel JS
Leukemia; 2015 Mar; 29(3):647-59. PubMed ID: 25092142
[TBL] [Abstract][Full Text] [Related]
5. Mapping the tumour human leukocyte antigen (HLA) ligandome by mass spectrometry.
Freudenmann LK; Marcu A; Stevanović S
Immunology; 2018 Jul; 154(3):331-345. PubMed ID: 29658117
[TBL] [Abstract][Full Text] [Related]
6. Mapping the HLA Ligandome of Colorectal Cancer Reveals an Imprint of Malignant Cell Transformation.
Löffler MW; Kowalewski DJ; Backert L; Bernhardt J; Adam P; Schuster H; Dengler F; Backes D; Kopp HG; Beckert S; Wagner S; Königsrainer I; Kohlbacher O; Kanz L; Königsrainer A; Rammensee HG; Stevanović S; Haen SP
Cancer Res; 2018 Aug; 78(16):4627-4641. PubMed ID: 29789417
[TBL] [Abstract][Full Text] [Related]
7. Sampling From the Proteome to the Human Leukocyte Antigen-DR (HLA-DR) Ligandome Proceeds Via High Specificity.
Mommen GP; Marino F; Meiring HD; Poelen MC; van Gaans-van den Brink JA; Mohammed S; Heck AJ; van Els CA
Mol Cell Proteomics; 2016 Apr; 15(4):1412-23. PubMed ID: 26764012
[TBL] [Abstract][Full Text] [Related]
8. Pre-fractionation Extends but also Creates a Bias in the Detectable HLA Class Ι Ligandome.
Demmers LC; Heck AJR; Wu W
J Proteome Res; 2019 Apr; 18(4):1634-1643. PubMed ID: 30784271
[TBL] [Abstract][Full Text] [Related]
9. The human leukocyte antigen-presented ligandome of B lymphocytes.
Hassan C; Kester MG; de Ru AH; Hombrink P; Drijfhout JW; Nijveen H; Leunissen JA; Heemskerk MH; Falkenburg JH; van Veelen PA
Mol Cell Proteomics; 2013 Jul; 12(7):1829-43. PubMed ID: 23481700
[TBL] [Abstract][Full Text] [Related]
10. The antigenic landscape of multiple myeloma: mass spectrometry (re)defines targets for T-cell-based immunotherapy.
Walz S; Stickel JS; Kowalewski DJ; Schuster H; Weisel K; Backert L; Kahn S; Nelde A; Stroh T; Handel M; Kohlbacher O; Kanz L; Salih HR; Rammensee HG; Stevanović S
Blood; 2015 Sep; 126(10):1203-13. PubMed ID: 26138685
[TBL] [Abstract][Full Text] [Related]
11. Landscape mapping of shared antigenic epitopes and their cognate TCRs of tumor-infiltrating T lymphocytes in melanoma.
Murata K; Nakatsugawa M; Rahman MA; Nguyen LT; Millar DG; Mulder DT; Sugata K; Saijo H; Matsunaga Y; Kagoya Y; Guo T; Anczurowski M; Wang CH; Burt BD; Ly D; Saso K; Easson A; Goldstein DP; Reedijk M; Ghazarian D; Pugh TJ; Butler MO; Mak TW; Ohashi PS; Hirano N
Elife; 2020 Apr; 9():. PubMed ID: 32314731
[TBL] [Abstract][Full Text] [Related]
12. Recognition of breast cancer-associated peptides by tumor-reactive, HLA-class I restricted allogeneic cytotoxic T lymphocytes.
Nguyen T; Naziruddin B; Dintzis S; Doherty GM; Mohanakumar T
Int J Cancer; 1999 May; 81(4):607-15. PubMed ID: 10225452
[TBL] [Abstract][Full Text] [Related]
13. The HLA ligandome of oropharyngeal squamous cell carcinomas reveals shared tumour-exclusive peptides for semi-personalised vaccination.
Mühlenbruch L; Abou-Kors T; Dubbelaar ML; Bichmann L; Kohlbacher O; Bens M; Thomas J; Ezić J; Kraus JM; Kestler HA; von Witzleben A; Mytilineos J; Fürst D; Engelhardt D; Doescher J; Greve J; Schuler PJ; Theodoraki MN; Brunner C; Hoffmann TK; Rammensee HG; Walz JS; Laban S
Br J Cancer; 2023 May; 128(9):1777-1787. PubMed ID: 36823366
[TBL] [Abstract][Full Text] [Related]
14. Natural Spleen Cell Ligandome in Transporter Antigen Processing-Deficient Mice.
Lorente E; Palomo C; Barnea E; Mir C; Del Val M; Admon A; López D
J Proteome Res; 2019 Sep; 18(9):3512-3520. PubMed ID: 31361958
[TBL] [Abstract][Full Text] [Related]
15. Human CD8 and CD4 T cell epitopes of epithelial cancer antigens.
Sato N; Nabeta Y; Kondo H; Sahara H; Hirohashi Y; Kashiwagi K; Kanaseki T; Sato Y; Rong S; Hirai I; Kamiguchi K; Tamura Y; Matsuura A; Takahashi S; Torigoe T; Ikeda H
Cancer Chemother Pharmacol; 2000; 46 Suppl():S86-90. PubMed ID: 10950155
[TBL] [Abstract][Full Text] [Related]
16. Immunopeptidome of hepatocytes isolated from patients with HBV infection and hepatocellular carcinoma.
de Beijer MTA; Bezstarosti K; Luijten R; Doff WAS; Boor PPC; Pieterman RFA; Bouzid R; Biesta PJ; Ijzermans JNM; Doukas M; de Man RA; Woltman AM; Demmers JAA; Buschow SI
JHEP Rep; 2022 Nov; 4(11):100576. PubMed ID: 36185575
[TBL] [Abstract][Full Text] [Related]
17. Direct interrogation of viral peptides presented by the class I HLA of HIV-infected T cells.
Yaciuk JC; Skaley M; Bardet W; Schafer F; Mojsilovic D; Cate S; Stewart CJ; McMurtrey C; Jackson KW; Buchli R; Olvera A; Cedeño S; Plana M; Mothe B; Brander C; West JT; Hildebrand WH
J Virol; 2014 Nov; 88(22):12992-3004. PubMed ID: 25165114
[TBL] [Abstract][Full Text] [Related]
18. Extensive major histocompatibility complex class I binding promiscuity for Mycobacterium tuberculosis TB10.4 peptides and immune dominance of human leucocyte antigen (HLA)-B*0702 and HLA-B*0801 alleles in TB10.4 CD8 T-cell responses.
Axelsson-Robertson R; Weichold F; Sizemore D; Wulf M; Skeiky YA; Sadoff J; Maeurer MJ
Immunology; 2010 Apr; 129(4):496-505. PubMed ID: 20002212
[TBL] [Abstract][Full Text] [Related]
19. Detection of naturally processed and HLA-A1-presented melanoma T-cell epitopes defined by CD8(+) T-cells' release of granulocyte-macrophage colony-stimulating factor but not by cytolysis.
Maeurer MJ; Martin D; Elder E; Storkus WJ; Lotze MT
Clin Cancer Res; 1996 Jan; 2(1):87-95. PubMed ID: 9816095
[TBL] [Abstract][Full Text] [Related]
20. Concordant expression of proto-oncogene promyelocytic leukemia and major histocompatibility antigen HLA class I in human hepatocellular carcinoma.
Xia M; Zhang JQ; Shen YQ; Xu LH; Chen AQ; Miao FQ; Xie W
Tissue Antigens; 2007 Oct; 70(4):272-82. PubMed ID: 17767548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]